PDGF as an Important Initiator for Neurite Outgrowth Associated with Fibrovascular Membranes in Proliferative Diabetic Retinopathy

References

• Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, Gardiner TA, Lyons TJ, Hammes HP, Simó R, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016 Mar;51:156–86.
   PubMed Web of Science ®Google Scholar
• Deuchler S, Schubert R, Singh P, Chedid A, Brui N, Kenikstul N, Kohnen T, Ackermann H, Koch F. Vitreous expression of cytokines and growth factors in patients with diabetic retinopathy – an investigation of their expression based on clinical diabetic retinopathy grade. PLoS One. 2021;16(5):e0248439. doi:https://doi.org/10.1371/journal.pone.0248439.
   PubMed Web of Science ®Google Scholar
• Ma T, Dong LJ, Du XL, Niu R, Hu BJ. Research progress on the role of connective tissue growth factor in fibrosis of diabetic retinopathy. Int J Ophthalmol. 2018;11:1550–54.
   PubMed Web of Science ®Google Scholar
• Opdenakker G, Abu El-Asrar A. Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy. Cell Mol Life Sci. 2019 Aug;76(16):3157–66. doi:https://doi.org/10.1007/s00018-019-03177-3.
   PubMed Web of Science ®Google Scholar
• Van Bergen T, Etienne I, Cunningham F, Moons L, Schlingemann RO, Feyen JHM, Stitt AW. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases. Prog Retin Eye Res. 2019 Mar;69:116–36.
   PubMed Web of Science ®Google Scholar
• Berrocal MH, Acaba LA. Surgical management of fibrovascular membranes. Advances in technique are improving patient outcomes. Retinal Physician. 2018;15:20–23.
   Google Scholar
• Lesnik Oberstein SY, Lewis GP, Chapin EA, Fisher SK. Ganglion cell neurites in human idiopathic epiretinal membranes. Br J Ophthalmol. 2008 Jul;92(7):981–85. doi:https://doi.org/10.1136/bjo.2007.132332.
   PubMed Web of Science ®Google Scholar
• Lesnik Oberstein SY, Lewis GP, Dutra T, Fisher SK. Evidence that neurites in human epiretinal membranes express melanopsin, calretinin, rod opsin and neurofilament protein. Br J Ophthalmol. 2010;95(2):266–72. doi:https://doi.org/10.1136/bjo.2010.180679.
   PubMed Web of Science ®Google Scholar
• Kim LA, Wong LL, Amarnani DS, Bigger-Allen AA, Hu Y, Marko CK, Eliott D, Shah VA, McGuone D, Stemmer-Rachamimov AO, et al. Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy. Mol Vis. 2015;21:673–87.
   PubMed Web of Science ®Google Scholar
• Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honoré JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008 Oct;14(10):1067–76. doi:https://doi.org/10.1038/nm.1873.
   PubMed Web of Science ®Google Scholar
• Wu D, Kanda A, Liu Y, Noda K, Murata M, Ishida S. Involvement of Müller glial autoinduction of TGF-β in diabetic fibrovascular proliferation via glial-mesenchymal transition. Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):29. doi:https://doi.org/10.1167/iovs.61.14.29.
   PubMed Web of Science ®Google Scholar
• Klaassen I, De Vries EW, Vogels IMC, van Kampen AHC, Bosscha MI, Steel DHW, Van Noorden CJF, Lesnik-Oberstein SY, Schlingemann RO. Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes. PLoS One. 2017;12(11):e0187304. doi:https://doi.org/10.1371/journal.pone.0187304.
   PubMed Web of Science ®Google Scholar
• Liu Z, Gao W, Wang Y, Zhang W, Liu H, Li Z. Neuregulin-1β regulates outgrowth of neurites and migration of neurofilament 200 neurons from dorsal root ganglial explants in vitro. Peptides. 2011 Jun;32(6):1244–48. doi:https://doi.org/10.1016/j.peptides.2011.04.005.
   PubMed Web of Science ®Google Scholar
• Bermingham-McDonogh O, McCabe KL, Reh TA. Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina. Development. 1996 May;122(5):1427–38. doi:https://doi.org/10.1242/dev.122.5.1427.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999 Oct;79(4):1283–316. doi:https://doi.org/10.1152/physrev.1999.79.4.1283.
   PubMed Web of Science ®Google Scholar
• Park N, Yoo JC, Ryu J, Hong SG, Hwang EM, Park JY. Copine1 enhances neuronal differentiation of the hippocampal progenitor HiB5 cells. Mol Cells. 2012 Dec;34(6):549–54. doi:https://doi.org/10.1007/s10059-012-0235-7.
   PubMed Web of Science ®Google Scholar
• Funa K, Sasahara M. The roles of PDGF in development and during neurogenesis in the normal and diseased nervous system. J Neuroimmune Pharmacol. 2014 Mar;9(2):168–81. doi:https://doi.org/10.1007/s11481-013-9479-z.
   PubMed Web of Science ®Google Scholar
• Smits A, Kato M, Westermark B, Nistér M, Heldin CH, Funa K. Neurotrophic activity of platelet-derived growth factor (PDGF): rat neuronal cells possess functional PDGF beta-type receptors and respond to PDGF. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8159–63. doi:https://doi.org/10.1073/pnas.88.18.8159.
   PubMed Web of Science ®Google Scholar
• Moon SW, Chung EJ, Jung SA, Lee JH. PDGF stimulation of Müller cell proliferation: contributions of c-JNK and the PI3K/Akt pathway. Biochem Biophys Res Commun. 2009 Oct 9;388(1):167–71. doi:https://doi.org/10.1016/j.bbrc.2009.07.144.
   PubMed Web of Science ®Google Scholar
• Klaassen I, Van Geest RJ, Kuiper EJ, van Noorden CJ, Schlingemann RO. The role of CTGF in diabetic retinopathy. Exp Eye Res. 2015 Apr;133:37–48. doi:https://doi.org/10.1016/j.exer.2014.10.016.
   PubMed Web of Science ®Google Scholar
• Boss JD, Singh PK, Pandya HK, Tosi J, Kim C, Tewari A, Juzych MS, Abrams GW, Kumar A. Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5594–603. doi:https://doi.org/10.1167/iovs.17-21973.
   PubMed Web of Science ®Google Scholar
• Gaublomme D, Buyens T, Moons L. Automated analysis of neurite outgrowth in mouse retinal explants. J Biomol Screen. 2013 Jun;18(5):534–43. doi:https://doi.org/10.1177/1087057112471989.
   PubMedGoogle Scholar
• Buyens T, Gaublomme D, Van Hove I, De Groef L, Moons L. Quantitative assessment of neurite outgrowth in mouse retinal explants. Methods Mol Biol. 2014;1162:57–71.
   PubMedGoogle Scholar
• Bollaerts I, Van Houcke J, Andries L, De Groef L, Moons L. Neuroinflammation as fuel for axonal regeneration in the injured vertebrate central nervous system. Mediators Inflamm. 2017;2017:9478542. doi:https://doi.org/10.1155/2017/9478542.
   PubMed Web of Science ®Google Scholar
• Van Hove I, Lefevere E, Moons L. ROCK inhibition as a novel potential strategy for axonal regeneration in optic neuropathies. Neural Regen Res. 2015 Dec;10(12):1949–50. doi:https://doi.org/10.4103/1673-5374.172311.
   PubMed Web of Science ®Google Scholar
• Van de Velde S, De Groef L, Stalmans I, Moons L, Van Hove I. Towards axonal regeneration and neuroprotection in glaucoma: rho kinase inhibitors as promising therapeutics. Prog Neurobiol. 2015 Aug;131:105–19. doi:https://doi.org/10.1016/j.pneurobio.2015.06.002.
   PubMed Web of Science ®Google Scholar
• Roberts WG, Whalen PM, Soderstrom E, Moraski G, Lyssikatos JP, Wang HF, Cooper B, Baker DA, Savage D, Dalvie D, et al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res. 2005 Feb 1;65(3):957–66.
   PubMed Web of Science ®Google Scholar
• Bollaerts I, Veys L, Geeraerts E, Andries L, De Groef L, Buyens T, Salinas-Navarro M, Moons L, Van Hove I. Complementary research models and methods to study axonal regeneration in the vertebrate retinofugal system. Brain Struct Funct. 2018 Mar;223(2):545–67.
   PubMed Web of Science ®Google Scholar
• Demoulin JB, Essaghir A. PDGF receptor signaling networks in normal and cancer cells. Cytokine Growth Factor Rev. 2014 Jun;25(3):273–83. doi:https://doi.org/10.1016/j.cytogfr.2014.03.003.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Nawaz MI, Ahmad A, De Zutter A, Siddiquei MM, Blanter M, Allegaert E, Gikandi PW, De Hertogh G, Van Damme J, et al. Evaluation of proteoforms of the transmembrane chemokines CXCL16 and CX3CL1, their receptors, and their processing metalloproteinases ADAM10 and ADAM17 in proliferative diabetic retinopathy. Front Immunol. 2020;11:601639. doi:https://doi.org/10.3389/fimmu.2020.601639.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Nawaz MI, Ahmad A, Siddiquei MM, Allegaert E, Gikandi PW, De Hertogh G, Opdenakker G. CD146/soluble CD146 pathway is a novel biomarker of angiogenesis and inflammation in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):32. doi:https://doi.org/10.1167/iovs.62.9.32.
   PubMed Web of Science ®Google Scholar
• Smits A, Ballagi AE, Funa K. PDGF-B-B exerts trophic activity on cultured GABA interneurons from the newborn rat cerebellum. Eur J Neurosci. 1993 Aug 1;5(8):986–94. doi:https://doi.org/10.1111/j.1460-9568.1993.tb00950.x.
   PubMed Web of Science ®Google Scholar
• Lewis GP, Betts KE, Sethi CS, Charteris DG, Lesnik-Oberstein SY, Avery RL, Fisher SK. Identification of ganglion cell neurites in human subretinal and epiretinal membranes. Br J Ophthalmol. 2006;91(9):1234–38. doi:https://doi.org/10.1136/bjo.2006.104612.
   PubMed Web of Science ®Google Scholar
• Rezzola S, Guerra J, Krishna Chandran AM, Loda A, Cancarini A, Sacristani P, Semeraro F, Presta M. VEGF-independent activation of Müller cells by the vitreous from proliferative diabetic retinopathy patients. Int J Mol Sci. 2021 Feb 22;22(4). doi:https://doi.org/10.3390/ijms22042179.
   PubMed Web of Science ®Google Scholar
• Low A, Kansagara D, Freeman M, Fu R, Bhavsar K, Faridi A, Kondo K, Paynter R. Comparative Clinical and Economic Effectiveness of Anti-vascular Endothelial Growth Factor Agents [Internet]. Washington (DC): Department of Veterans Affairs (US); 2017 Jan. PMID: 29369569.
   Google Scholar
• Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest. 2003 Oct;112(8):1142–51. doi:https://doi.org/10.1172/JCI200318549.
   PubMed Web of Science ®Google Scholar
• Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003 May;111(9):1287–95. doi:https://doi.org/10.1172/JCI200317929.
   PubMed Web of Science ®Google Scholar
• Erber R, Thurnher A, Katsen AD, Groth G, Kerger H, Hammes HP, Menger MD, Ullrich A, Vajkoczy P. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J. 2004 Feb;18(2):338–40. doi:https://doi.org/10.1096/fj.03-0271fje.
   PubMed Web of Science ®Google Scholar
• Mancuso MR, Davis R, Norberg SM, O’Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B, et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest. 2006 Oct;116(10):2610–21. doi:https://doi.org/10.1172/JCI24612.
   PubMed Web of Science ®Google Scholar
• Mabry R, Gilbertson DG, Frank A, Vu T, Ardourel D, Ostrander C, Stevens B, Julien S, Franke S, Meengs B, et al. A dual-targeting PDGFRbeta/VEGF – a molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo. MAbs. 2010 Jan-Feb;2(1):20–34. doi:https://doi.org/10.4161/mabs.2.1.10498.
   PubMed Web of Science ®Google Scholar
• Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol. 2006 Jun;168(6):2036–53. doi:https://doi.org/10.2353/ajpath.2006.050588.
   PubMed Web of Science ®Google Scholar
• Strittmatter K, Pomeroy H, Marneros AG. Targeting platelet-derived growth factor receptor β(+) scaffold formation inhibits choroidal neovascularization. Am J Pathol. 2016 Jul;186(7):1890–99. doi:https://doi.org/10.1016/j.ajpath.2016.02.018.
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Ciulla TA, Ciardella AP, Devin F, Dugel PU, Eandi CM, Masonson H, Monés J, Pearlman JA, Quaranta-El Maftouhi M, et al. Dual antagonism of PDGF and VEGF in neovascular age-related macular degeneration: a Phase IIb, multicenter, randomized controlled trial. Ophthalmology 2017 Feb;124(2):224–34. doi:https://doi.org/10.1016/j.ophtha.2016.10.010.
   PubMed Web of Science ®Google Scholar
• Dunn EN, Hariprasad SM, Sheth VS. An overview of the fovista and rinucumab trials and the fate of anti-PDGF medications. Ophthalmic Surg Lasers Imaging Retina. 2017 Feb 1;48(2):100–04. doi:https://doi.org/10.3928/23258160-20170130-02.
   PubMed Web of Science ®Google Scholar
• Cox OT, Simpson DA, Stitt AW, Gardiner TA. Sources of PDGF expression in murine retina and the effect of short-term diabetes. Mol Vis. 2003 Dec;10(9):665–72.
   Google Scholar
• Biswas SK, Zhao Y, Nagalingam A, Gardner TW, PDG SL. F- and insulin/IGF-1-specific distinct modes of class IA PI 3-kinase activation in normal rat retinas and RGC-5 retinal ganglion cells. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3687–98. doi:https://doi.org/10.1167/iovs.07-1455.
   PubMed Web of Science ®Google Scholar
• Díaz-Lezama N, Wolf A, Koch S, Pfaller AM, Biber J, Guillonneau X, Langmann T, Grosche A. PDGF Receptor Alpha Signaling Is Key for Müller Cell Homeostasis Functions. Int J Mol Sci. 2021 Jan 25;22(3):1174. doi:https://doi.org/10.3390/ijms22031174
   Google Scholar